HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul G Richardson Selected Research

Multiple Myeloma

10/2022Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.
10/2022Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review.
10/2022Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA.
6/2022Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial.
4/2022Melflufen for the treatment of multiple myeloma.
2/2022Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
1/2022Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma.
1/2022Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
1/2022An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment.
1/2022Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul G Richardson Research Topics

Disease

329Multiple Myeloma
10/2022 - 06/2002
95Neoplasms (Cancer)
04/2022 - 06/2002
24Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2022 - 06/2007
24Thrombocytopenia (Thrombopenia)
02/2022 - 12/2005
22Disease Progression
01/2022 - 06/2005
22Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 07/2006
16Fatigue
01/2022 - 07/2006
15Neutropenia
02/2022 - 10/2008
11Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 06/2003
9Anemia
11/2018 - 09/2009
9Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2016 - 04/2003
8Exanthema (Rash)
01/2018 - 01/2012
7Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 11/2006
6Plasmacytoma
01/2021 - 09/2002
6Lymphoma (Lymphomas)
01/2021 - 01/2005
6Residual Neoplasm
12/2020 - 10/2016
6Leukemia
10/2017 - 01/2004
6Inflammation (Inflammations)
01/2017 - 06/2003
5Pneumonia (Pneumonitis)
02/2022 - 01/2019
5Hemorrhage
01/2022 - 06/2007
4COVID-19
02/2022 - 01/2022
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2022 - 09/2003
4Infections
01/2021 - 03/2011
4Necrosis
12/2018 - 04/2005
4Diarrhea
01/2018 - 10/2013
4Nausea
10/2017 - 07/2006
3Hypotension (Low Blood Pressure)
11/2022 - 03/2016
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 09/2003
3Sepsis (Septicemia)
01/2022 - 12/2019
3Paraproteinemias (Monoclonal Gammopathy)
08/2017 - 09/2008
3Asthenia
06/2016 - 02/2010
3Osteonecrosis (Kienbock's Disease)
08/2014 - 07/2005
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2012 - 02/2005
3Bone Diseases (Bone Disease)
01/2012 - 11/2006
3Human Influenza (Influenza)
03/2011 - 06/2003
3Breast Neoplasms (Breast Cancer)
02/2011 - 04/2005
3Renal Insufficiency (Renal Failure)
11/2010 - 11/2006

Drug/Important Bio-Agent (IBA)

146Bortezomib (Velcade)FDA Link
10/2022 - 09/2002
114Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 06/2002
91Lenalidomide (CC 5013)FDA Link
10/2022 - 11/2002
64Proteasome InhibitorsIBA
02/2022 - 06/2002
34Pharmaceutical PreparationsIBA
04/2022 - 11/2002
25pomalidomideIBA
02/2022 - 03/2013
25Thalidomide (Thalomid)FDA Link
01/2021 - 06/2002
22ixazomibIBA
12/2021 - 08/2014
22Proteasome Endopeptidase Complex (Proteasome)IBA
10/2020 - 10/2002
19defibrotideIBA
01/2022 - 06/2007
18Monoclonal AntibodiesIBA
12/2021 - 09/2003
18PanobinostatIBA
11/2021 - 11/2011
17Melphalan (Alkeran)FDA LinkGeneric
01/2022 - 03/2003
15daratumumabIBA
01/2022 - 06/2015
14Proteins (Proteins, Gene)FDA Link
10/2020 - 05/2003
13isatuximabIBA
10/2022 - 05/2018
12Immunomodulating AgentsIBA
12/2021 - 04/2009
12NF-kappa B (NF-kB)IBA
04/2010 - 06/2002
11Biological ProductsIBA
01/2021 - 06/2002
11Prednisone (Sone)FDA LinkGeneric
06/2019 - 08/2008
10Alkylating AgentsIBA
04/2022 - 08/2006
9melflufenIBA
04/2022 - 01/2016
8elotuzumabIBA
06/2022 - 06/2012
8selinexorIBA
01/2022 - 01/2019
8Histone Deacetylase InhibitorsIBA
11/2021 - 04/2003
8Interleukin-6 (Interleukin 6)IBA
07/2010 - 08/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 04/2005
7CytokinesIBA
07/2010 - 03/2004
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2007 - 09/2002
6DNA (Deoxyribonucleic Acid)IBA
01/2019 - 03/2003
5Peptides (Polypeptides)IBA
04/2022 - 06/2003
5Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2014
5carfilzomibIBA
10/2020 - 08/2014
5marizomibIBA
10/2020 - 01/2010
5CreatinineIBA
01/2019 - 01/2011
5Immunoglobulins (Immunoglobulin)IBA
01/2018 - 12/2007
5Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2015 - 10/2002
5Diphosphonates (Bisphosphonates)IBA
08/2014 - 07/2005
5Antineoplastic Agents (Antineoplastics)IBA
08/2013 - 06/2004
5VorinostatFDA Link
07/2013 - 04/2003
5perifosineIBA
08/2012 - 05/2006
5tanespimycin (17AAG)IBA
06/2011 - 02/2006
4AminopeptidasesIBA
04/2022 - 09/2020
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2007 - 10/2003
3AntibodiesIBA
01/2021 - 08/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 03/2003
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 04/2005
3Immunoconjugates (Immunoconjugate)IBA
10/2020 - 12/2018
3B-Cell Maturation AntigenIBA
10/2020 - 12/2018
3belantamab mafodotinIBA
10/2020 - 12/2018
3AntigensIBA
12/2018 - 06/2003
3Phosphotransferases (Kinase)IBA
06/2014 - 05/2004
3EnzymesIBA
01/2013 - 03/2004
3Transcription Factors (Transcription Factor)IBA
09/2012 - 06/2002

Therapy/Procedure

147Therapeutics
11/2022 - 04/2003
31Stem Cell Transplantation
06/2022 - 09/2005
18Drug Therapy (Chemotherapy)
12/2020 - 06/2003
14Hematopoietic Stem Cell Transplantation
11/2022 - 06/2007
9Transplantation
06/2022 - 09/2003
7Cell Transplantation
12/2021 - 09/2013
5Immunotherapy
01/2018 - 06/2003
4Radiotherapy
10/2020 - 05/2005
3Drug Tapering
06/2014 - 07/2006